Abbott's XIENCE PRIME stent wins FDA approval

11/2/2011 | Reuters

The FDA has granted Abbott Laboratories approval for its XIENCE PRIME everolimus-eluting stent for use in treating patients with coronary artery disease. The device has an improved design that allows more flexibility and accuracy in stent delivery and placement.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR
Compliance Sr Mgr
Amgen
Thousand Oaks, CA
Paralegal
Mylan Inc.
Washington, DC
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR